| HOME >> MEDICINE >> TECHNOLOGY |
Table 5.4 Influenza Vaccine Sales Revenues ($m) and Growth Rates (%) for EU5 Countries, 2016-2021
Table 5.5 Influenza Vaccine Sales Revenues ($m) and Growth Rates (%) for EU5 Countries, 2009-2015
Table 5.6 Influenza Vaccine Sales Revenues ($m) and Growth Rates (%) for EU5 Countries, 2016-2021
Table 5.7 Vaccine Coverage Rates (%) in UK, Germany, France, Spain and Italy, 2008-2009
Table 5.8 Influenza Vaccine Sales Revenues ($m) and Growth Rates (%) in the US, 2009-2015
Table 5.9 Influenza Vaccine Sales Revenues ($m) and Growth Rates (%) in the US, 2016-2021
Table 5.10 Top Flu Vaccine Suppliers in the US for the 2008-2009 Season
Table 5.11 Influenza Vaccine Coverage among Adults in the US, 2004-2005
Table 5.12 Influenza Vaccine Coverage among Children in the US, 2004-2005
Table 5.13 Paediatric Influenza Vaccine Price ($) List (May 1, 2009)
Table 5.14 Adult Influenza Vaccines Price ($) List (May 1, 2009)
Table 5.15 Influenza Vaccine Sales Revenues ($bn) and Growth Rates (%) in Japan, 2009-2015
Table 5.16 Influenza Vaccine Sales Revenues ($bn) and Growth Rates (%) in Japan, 2016-2021
Table 5.17 Influenza Vaccine Price ($) per Unit in Japan, 2009-2021
Table 6.1 Influenza Vaccine Sales Revenues ($bn) and Growth Rates (%) for Emerging & Other Markets, 2009-2015
Table 6.2 Influenza Vaccine Sales Revenues ($bn) and Growth Rates (%) for Emerging & Other Markets, 2016-2021
Table 6.3 Leading Influenza Vaccine Manufacturers in Emerging & Other Markets, 2010
Table 6.4 Demographic Statistics for China, 2010
Table 6.5 Estimated Number of Vaccinated People in China, 2009, 2012, 2016 and 2021
Table 6.6 Influenza Vaccine Sales Revenues ($bn) and Growth Rates (%) in China, 2009-2015
Table 6.7 Influenza Vaccine Sales Revenues ($bn) and Growth Rates (%) in China, 2016-2021<
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |